Health Care Service Corporation prior authorization criteria
Documentation packets and P2P preparation by drug—for prescribers and PA staff. Verify the current member-specific payer criteria and timing before submission.
Health Care Service Corporation reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. The applicable product, plan terms, request type, urgency, and governing law determine the decision and appeal clocks. Confirm both in the current member-specific source and denial notice. Criteria by drug appear below.
Prior authorization criteria by drug
Each page covers Health Care Service Corporation's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at Health Care Service Corporation →
- Aflibercept at Health Care Service Corporation →
- Apixaban at Health Care Service Corporation →
- Atezolizumab at Health Care Service Corporation →
- Atogepant at Health Care Service Corporation →
- Benralizumab at Health Care Service Corporation →
- Bevacizumab at Health Care Service Corporation →
- Bictegravir at Health Care Service Corporation →
- Buprenorphine at Health Care Service Corporation →
- Dapagliflozin at Health Care Service Corporation →
- Dulaglutide at Health Care Service Corporation →
- Dupilumab at Health Care Service Corporation →
- Eculizumab at Health Care Service Corporation →
- Elexacaftor Tezacaftor Ivacaftor at Health Care Service Corporation →
- Empagliflozin at Health Care Service Corporation →
- Erenumab at Health Care Service Corporation →
- Evolocumab at Health Care Service Corporation →
- Faricimab at Health Care Service Corporation →
- Fingolimod at Health Care Service Corporation →
- Fremanezumab at Health Care Service Corporation →
- Galcanezumab at Health Care Service Corporation →
- Glecaprevir Pibrentasvir at Health Care Service Corporation →
- Guselkumab at Health Care Service Corporation →
- Ibrutinib at Health Care Service Corporation →
- Imatinib at Health Care Service Corporation →
- Inclisiran at Health Care Service Corporation →
- Infliximab at Health Care Service Corporation →
- Ixekizumab at Health Care Service Corporation →
- Lenalidomide at Health Care Service Corporation →
- Liraglutide at Health Care Service Corporation →
- Lisdexamfetamine at Health Care Service Corporation →
- Mepolizumab at Health Care Service Corporation →
- Methylphenidate at Health Care Service Corporation →
- Naltrexone at Health Care Service Corporation →
- Natalizumab at Health Care Service Corporation →
- Nintedanib at Health Care Service Corporation →
- Nivolumab at Health Care Service Corporation →
- Nusinersen at Health Care Service Corporation →
- Ocrelizumab at Health Care Service Corporation →
- Ofatumumab at Health Care Service Corporation →
- Omalizumab at Health Care Service Corporation →
- Ozanimod at Health Care Service Corporation →
- Palbociclib at Health Care Service Corporation →
- Pembrolizumab at Health Care Service Corporation →
- Pirfenidone at Health Care Service Corporation →
- Ribociclib at Health Care Service Corporation →
- Rimegepant at Health Care Service Corporation →
- Risankizumab at Health Care Service Corporation →
- Rituximab at Health Care Service Corporation →
- Rivaroxaban at Health Care Service Corporation →
- Sacubitril Valsartan at Health Care Service Corporation →
- Secukinumab at Health Care Service Corporation →
- Semaglutide at Health Care Service Corporation →
- Sofosbuvir at Health Care Service Corporation →
- Tafamidis at Health Care Service Corporation →
- Tenofovir Alafenamide at Health Care Service Corporation →
- Tezepelumab at Health Care Service Corporation →
- Tirzepatide at Health Care Service Corporation →
- Tofacitinib at Health Care Service Corporation →
- Trastuzumab at Health Care Service Corporation →
- Upadacitinib at Health Care Service Corporation →
- Ustekinumab at Health Care Service Corporation →
Generate a Health Care Service Corporation PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to Health Care Service Corporation's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com